Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 50039344
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335165(3-[2-(1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-6-(2-tr...)
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 0.413nMAssay Description:Inhibition of human TRPM8 expressed in HEK293 cells assessed as inhibition of cold-induced channel current by whole cell electrophysiologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335170(3-[5-(2-Fluoro-6-trifluoromethylphenyl)-1H-benzimi...)
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335160(2-(1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-6-(2-trifl...)
Affinity DataIC50: 0.700nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335171(3-[5-(2-Fluoro-6-trifluoromethoxyphenyl)-1H-benzim...)
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335173(8,8-Difluoro-3-[5-(2-trifluoromethylphenyl)-1H-ben...)
Affinity DataIC50: 0.900nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335164(3-[5-(2-Chlorophenyl)-7-trifluoromethyl-1H-benzimi...)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335154(3-[5-(2-Trifluoromethoxyphenyl)-1H-benzimidazol-2-...)
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335163(3-[5-(2-Trifluoromethoxyphenyl)-7-trifluoromethyl-...)
Affinity DataIC50: 1.20nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335174(3-[7-Trifluoromethyl-5-(2-trifluoromethylphenyl)-1...)
Affinity DataIC50: 1.40nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335162(3-[5-(2-Fluorophenyl)-7-trifluoromethyl-1H-benzimi...)
Affinity DataIC50: 1.70nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335158(3-[7-Fluoro-5-(2-trifluoromethylphenyl)-1H-benzimi...)
Affinity DataIC50: 2.20nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335169(3-[5-(2,6-Difluorophenyl)-1H-benzimidazol-2-yl]-1-...)
Affinity DataIC50: 2.30nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335151(3-[5-(2-Chlorophenyl)-1H-benzimidazol-2-yl]-1-oxa-...)
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335153(3-[5-(2-Difluoromethoxyphenyl)-1H-benzimidazol-2-y...)
Affinity DataIC50: 2.5nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335161(3-[7-Bromo-5-(2-trifluoromethylphenyl)-1H-benzimid...)
Affinity DataIC50: 2.70nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335155(3-[5-(2-Fluorophenyl)-1H-benzimidazol-2-yl]-1-oxa-...)
Affinity DataIC50: 2.90nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 3nMAssay Description:Antagonist activity at human TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation at 0.2 uM by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335156(3-[5-(2-Trifluoromethyl-phenyl)-1H-benzimidazol-2-...)
Affinity DataIC50: 3.10nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335159(3-[7-Chloro-5-(2-trifluoromethylphenyl)-1H-benzimi...)
Affinity DataIC50: 3.30nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at rat TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation at 0.2 uM by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335175(3-[7-Chloro-5-(2-trifluoromethyl-phenyl)-1H-benzim...)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335166(2-(5-(2-(Trifluoromethyl)phenyl)-1H-benzo[d]imidaz...)
Affinity DataIC50: 6nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335172(3-[5-(2-Trifluoromethylphenyl)-1H-benzimidazol-2-y...)
Affinity DataIC50: 6.70nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335168(2-{2-[2-(1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-1H-b...)
Affinity DataIC50: 7.90nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335167(2-(5-(2-(Trifluoromethyl)phenyl)-1H-benzimidazol-2...)
Affinity DataIC50: 61nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetTransient receptor potential M8 protein(Dog)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335152(3-[5-(2,2-Difluorobenzo[1,3]dioxol-4-yl)-1H-benzim...)
Affinity DataIC50: 91nMAssay Description:Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335156(3-[5-(2-Trifluoromethyl-phenyl)-1H-benzimidazol-2-...)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335160(2-(1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-6-(2-trifl...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335161(3-[7-Bromo-5-(2-trifluoromethylphenyl)-1H-benzimid...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335159(3-[7-Chloro-5-(2-trifluoromethylphenyl)-1H-benzimi...)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335158(3-[7-Fluoro-5-(2-trifluoromethylphenyl)-1H-benzimi...)
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335165(3-[2-(1-Oxa-2-aza-spiro[4.5]dec-2-en-3-yl)-6-(2-tr...)
Affinity DataIC50: 6.80E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335162(3-[5-(2-Fluorophenyl)-7-trifluoromethyl-1H-benzimi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335163(3-[5-(2-Trifluoromethoxyphenyl)-7-trifluoromethyl-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335164(3-[5-(2-Chlorophenyl)-7-trifluoromethyl-1H-benzimi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes after 15 misMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Janssen Pharmaceutica

Curated by ChEMBL
LigandPNGBDBM50335157(3-[7-Trifluoromethyl-5-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50: 1.60E+4nMAssay Description:Displacement of [3H]astemizole from human ERG by whole cell patch-clamp techniqueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2013
Entry Details Article
PubMed